Rami Burstein, Ph.D. is the John Hedley-Whyte Professor of Anaesthesia and Neuroscience at Harvard Medical School, and the Vice Chairman of Research in the Department of Anesthesia and Critical Care at Beth Israel Deaconess Medical Center.
Professor Burstein is an appointed member of the Interagency Pain Research Coordinating Committee (IPRCC), which consists of representative from the NIH, CDC, FDA and the Department of Health and Human Services and whose mission is to implement the Patient Protection and Affordable Care Act; and the current (Co)-Chairman of the Scientific Program Committee for the International Headache Conference meeting in 2019 and the European Headache Federation Annual Meeting in 2018. He is a past member of the Board of Directors of both the American and the International Headache Societies.
Among Professor Burstein accomplishments are the discoveries of the spinohypothalamic tract, peripheral and central sensitization role in migraine pathophysiology and treatment, mechanisms of action of several anti-migraine drugs, the neurobiology of photophobia, and most recently, the glymphatic system role in migraine. Throughout the years, he has received numerous awards for his discoveries. These include the prestigious Javits Neuroscience Merit Award (National Advisory Neurological Disorder and Stroke Council), the Harold Wolff Awards for 2003 and 2005 (American Headache Society), the Cephalalgia Awards for best papers published in Cephalalgia in 2013 and 2015 (International Headache Society), the Seymour Diamond Lectureship Award in 2012 and 2015, and the 2010 Alan Edwards Center for Research on Pain Award )McGill University).
In the past 10 years, he has been serving as a reviewer for the NIH, the Welcome Trust, the Canadian Institute of Health Research, Science, the Dana Foundation Program in Brain and Immuno-imaging, Rita Allen Foundation, Brookdale Foundation, and the Ellison New Scholars Program in Aging.
Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is Assprof. and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands, and director of the Headache Clinic. She is chair of the scientific-and migraine-guideline-committeeof the Dutch Headache Society. She was member of the ICHD-III Classification Committee and is IHS board member. She has published >250 scientific papers and several book chapters on headache and migraine. She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI-award).
Her research interest is to unravel neurobiological and molecular triggering mechanisms leading to migraine attacks, and to identify treatment targets for the acute treatment and prevention of attacks and disease-chronification. In addition, her group is studying the pathogenesis of rare monogenic disorders such as Familial Hemiplegic Migraine and Cerebral Hereditary Angiopathies which may serve as genetic models to study the pathogenesis of migraine but also improve mechanistic insight in the pathophysiology of other common neurovascular disorders, including stroke and dementia. With this she is increasingly involved in the migraine-stroke relationship with a special focus on women, and has a special interest to study female-specific trigger factors and complications in migraine.
Dr Anna Andreou is the Director of Headache Research of the Headache Centre, Guy’s and St Thomas’s NHS Trust and a Senior Lecturer at Wolfson CARD, King’s College London.
She completed her PhD in Headache-Neurology at the Institute of Neurology-Queen Square, before moving to the University of California San Francisco, where she focused her research on the investigation of brain networks involved in migraine pathophysiology and the effectiveness of neuromodulation in headaches. She became a Primary Investigator for headache research at Imperial College London, before moving to King’s College London.
Anna has received a number of awards including the “Frontiers in Headache Research" Scholarship Awards by the American Headache Society, the Early Research Career Grant by the International Association for the Study of Pain and the New Investigators Excellence award by the International Headache Society. She is currently a Senior Fellow of the Migraine Trust.
Anna is an active member of the International Headache Society since 2005. She is currently the Chair of the IHS Electronics Media Committee and past-chair of the Trainees and Residents SIG for four years.
Dawn C.BusePhD is a Clinical Professor of Neurology at Albert Einstein College of Medicine in New York City, a member of the Board of Directors of the American Headache Society, and a licensed psychologist. She conducts research on migraine, pain and the burden and effects of living with chronic diseases. Sheis a co-investigator on the American Migraine Prevalence and Prevention (AMPP) Study, the Chronic Migraine Epidemiology and Outcomes (CAMEO) Study, the Migraine Signature Study (MSS), the International Burden of Migraine (IBMS) Study, the Migraine, Symptoms and Treatment in America (MAST) Study and the OVERCOME Study. She has more than 150 scientific publications and has won eight US and international research awards and two professional awards for her work in the field of migraine. Dr.Buseis the Psychological andBehavioralsection editor forCurrent Pain and Headache Reports. Her website (dawnbuse.com) offers free guided visual imagery and relaxation exercises as well as research abstracts. Follow her on twitter at @dawnbuse.
Fabíola Dach is Professor of Neurology of School of Medicine of Ribeirão Preto, University of Sao Paulo (FMRP-USP), where she did her PhD on Neurology. She is the Chair of outpatient clinics of headache in childhood, of headache in adulthood and of neuropathic pain at the University Hospital of FMRP-USP. She acts in assistency, education and research on headache field.
Hans-Christoph Diener, MD, PhD is a member of the Faculty of Medicine at the University Duisburg-Essen in Essen, Germany. He was Chairman of the Department of Neurology at the University of Essen from 1989 to April 2016 and Professor of Clinical Neurosciences at the Medical Faculty of the University Duisburg-Essen from 2016-2019. He was President of the German Neurological Society (2003-2004), the European Headache Federation (2006-2008) and the International Headache Society (2009-2011).
Dr.Diener’s special research interests focus on headache and stroke. He was the PI of >30 trials in the acute treatment or prophylaxis of migraine, tension-type headache or cluster headache. Dr. Diener performed major studies in the epidemiology of chronic headache supported by the German Ministry of Research and Education.
Prof. Diener has authored or co-authored 947 articles in peer reviewed journals (185 as first author, 21 in the NEJM), 465 invited reviews, and 364 book chapters, and served as the editor or author of 83 books. His h-index is 108. He is the editor of Neurologie Up2dtae, and Arzneimitteltherapie, deputy editor of Cephalalgia and serves on the editorial board of Lancet Neurology. He chairs the Guidelines Committee of the German Society of Neurology and co-chairs the Clinical Trials Guidelines Committee of the IHS.
Andrew D. Hershey, MD, PhD, FAAN, FAHS, received a Bachelor of Science with Highest Distinction and Honors in Biochemistry degree from the University of Iowa followed by the MD/PhD program at Washington University, St. Louis, Missouri. After earning his MD and PhD, Dr. Hershey was a resident in pediatrics, neurology and child neurology at St. Louis Children's Hospital and Barnes-Jewish Hospital, St. Louis, MO.
Dr. Hershey joined the faculty at Cincinnati Children's Hospital Medical Center and the University of Cincinnati, College of Medicine, where he became the director of the Cincinnati Children’s Headache Center and is the Endowed Chair and Director of Neurology and a Professor of Pediatrics and Neurology at the University of Cincinnati, College of Medicine.
Dr. Hershey's research interests currently include the improved diagnosis and treatment of childhood headache disorders, characterization of outcome responses, studies in new pharmacological and non-pharmacological treatment regimes, and the genomics of migraines. Through a wide variety of projects, he has been NIH funded since 2003, including a PI with Dr. Scott Powers at CCHMC and Dr. Christopher Coffey at the University of Iowa of an U01on the comparative effectiveness of amitriptyline and topiramate in the prevention of pediatric migraine.
Anders Hougaard is a medical doctor and post-doctoral researcher at the Danish Headache Center. Anders has been active in clinical headache research since 2009 and completed his PhD in Neuroscience on the topic of advanced magnetic resonance imaging investigations in migraine with aura in 2014. His current main research interests include the pathophysiology of migraine (in particular migraine aura), neuroimaging methods in headache (MRI, fMRI, SPECT, PET), and headache trigger factors.
Arne May is a Professor of Neurology in the Department of Systems Neuroscience at the University of Hamburg and head of the headache outpatient clinic and the facial outpatient clinic of the University clinic of Hamburg. His major research interests are the basic mechanisms of facial and headpain, the chronification of pain and plasticity within the human brain. The work of his group involves human imaging studies in primary headache as well as experimental studies of trigeminovascular nociception, with the aim of understanding how to modulate facial and headache syndromes and chronicity of pain. Prior to his position at the University of Hamburg, Professor May was a clinician and conducted research into pain and headache syndromes at the University of Regensburg. Prior to this he completed his residency in the Neurology Department of the University of Essen, followed by post-doctorate studies at the Institute of Neurology in London with Peter Goadsby. Professor May is currently a member of the Board of trustees of the International Headache Society since 2013. He has published around 300 original and review articles with an h-index of 66 and is since 2016 the Editor of Cephalalgia.
Lars Jacob Stovner, MD, neurologist, born 1953, is professor of Neurology at NTNU, the Norwegian University of Science and Technology (NTNU), Trondheim, Norway. He is former head of the Department of neurology in Trondheim, and of the Department of Neuroscience at NTNU. He has been in charge of the Norwegian Advisory Unit on Headaches from its launch in 2000.
His group has performed several studies on the treatment of migraine, cluster headache and cervicogenic headache, and, in particular, it has developed candesartan, an AII blocker, and lisinopril, an ACE inhibitor, as useful migraine prophylactics. A main interest is epidemiological research on the prevalence, causes and consequences of migraine and other headaches, mostly based on the HUNT study. He has chaired an international group aiming to document headache as a public health problem worldwide, in the capacity of director of Lifting The Burden: The Global Campaign Against Headache, through collaboration with the World Health Organization, as contributor to the Global Burden of Disease Studies, and as partner in a EU project (Eurolight). He has also contributed to studies on the cost of headache, through participation in the European Brain Council.
Dr. Thomas N. Ward grew up in Portsmouth, NH where he attended the public school system. He graduated from Dartmouth College cum laude in 1975 and from Dartmouth Medical School with honors in 1980. He was elected a member of AOA.
He was an intern and resident in Internal Medicine at Albany Medical Center from 1980-1982 then a resident in Neurology from 1982-1985 at Dartmouth-Hitchcock Medical Center. Subsequently he practiced Neurology at Laconia Clinic in Laconia, NH until returning to Dartmouth-Hitchcock Medical Center in 1989 where he founded their headache clinic.
Dr. Ward is a Fellow of the American Headache Society and of the American Academy of Neurology as well as the American Neurological Association. He is President of the Headache Cooperative of New England and certified in the subspecialty of Headache Medicine by the United Council for Neurologic Subspecialties. He is Active Emeritus Professor of Neurology at the Geisel School of Medicine at Dartmouth. He is the Editor in Chief of the journal Headache: the journal of head and face pain.